LC Engineering key terms

Any current that flows from a device's conductive parts to earth or to a patient rather than through the intended circuit. It is measured in microamperes and compared against limits based on the applied part type.

The portion of a medical device designed to physically contact the patient to perform its function. Its classification as Type B, BF, or CF sets the allowable leakage current and the degree of electrical isolation required.

A cardiac floating applied part engineered for direct electrical contact with the heart, offering the highest level of patient isolation. It carries the strictest leakage current limits of any applied part classification.

Current flowing through the patient between an applied part and earth, or between multiple applied parts. It is the most safety-critical leakage measurement because the current path passes directly through body tissue.

A test instrument that measures leakage current, ground wire resistance, and insulation resistance on medical equipment. It simulates normal and single-fault conditions such as an open ground or reversed polarity.

A testing scenario in which one protective feature, such as the earth ground conductor, is deliberately defeated to verify the device remains safe. Leakage limits under single fault are more permissive but still bounded.

A measurement confirming that exposed metal on a device is bonded to the power cord's earth pin with low resistance, typically under 0.1 to 0.2 ohms. It verifies the protective earth path can carry fault current safely.

Physiological harm caused by externally applied current passing through the body, on the order of milliamperes, capable of triggering ventricular fibrillation. It is distinguished from microshock, which involves far smaller currents delivered directly to cardiac tissue.

Ventricular fibrillation induced by very small currents, roughly 10 to 100 microamperes, conducted directly to the heart through an intracardiac catheter or similar low-impedance pathway. It drives the strict Type CF leakage requirements.

A disorganized, chaotic electrical activity of the ventricles that eliminates effective pumping and causes cardiac arrest within seconds. It is the primary lethal arrhythmia targeted by electrical safety limits and defibrillation therapy.

A device that delivers a controlled high-energy electrical shock across the chest to terminate ventricular fibrillation and restore an organized rhythm. Implantable and automated external versions differ in energy delivery and degree of automation.

A verification that a defibrillator discharges the selected energy within tolerance, measured with a calibrated analyzer into a test load. It confirms both delivered energy accuracy and charge time performance.

The process of comparing an instrument's measurement against a traceable reference standard and adjusting it to reduce error. Results are documented with as-found and as-left values to establish a maintenance history.

Scheduled inspection, cleaning, testing, and part replacement performed on equipment to prevent failure and confirm safe performance. Intervals are set by manufacturer recommendations, risk level, and clinical use intensity.

Software that tracks equipment inventory, work orders, maintenance schedules, parts, and service history across a healthcare facility. It provides the data used for compliance reporting and capital replacement planning.

A documented request or authorization for maintenance activity on a specific device, recording the problem, actions taken, parts used, and completion status. It creates the auditable record regulators and accreditation surveys expect.

A unique identifier assigned to each device in a facility's asset register, linking the physical unit to its service history, manuals, and recall status. It enables tracking across departments and locations.

A manufacturer or regulatory action to correct or remove a device from service because of a safety defect or regulatory violation. Clinical engineering must identify affected units by model and serial number and act promptly.

A standardized labeling system that assigns a distinct code to each device model and, where required, each production unit. It supports traceability, recall management, and adverse event reporting.

The regulatory requirement for manufacturers and facilities to report device-related deaths, serious injuries, and malfunctions to the appropriate authority within defined timeframes. Clinical engineers often supply the technical facts behind a report.

An unexpected occurrence involving death or serious physical or psychological injury, or the risk thereof, that triggers immediate investigation and response. Device failures and use errors may be classified this way.

A structured method for identifying the underlying system and process factors that contributed to an adverse event, rather than blaming an individual. Findings drive corrective actions such as redesign, training, or policy change.

A proactive team method that lists the ways a process or device can fail, rates each by severity, likelihood, and detectability, and prioritizes mitigation. It is widely used before installing new clinical technology.

A structured evaluation of a device's clinical effectiveness, safety, cost, and operational impact before purchase or adoption. It supports capital planning and helps avoid acquiring equipment that duplicates existing capability.

The budgeting and lifecycle process for acquiring, maintaining, and replacing high-cost medical devices over multiple years. It weighs utilization, service costs, obsolescence, and clinical demand.

The foundational international standard for basic safety and essential performance of medical electrical equipment. It defines leakage limits, applied part classifications, and test conditions that safety testing programs follow.

The clinical functions of a device whose loss or degradation beyond specified limits would create an unacceptable risk. It guides what must be verified during testing and what must be preserved during electromagnetic disturbance.

The ability of a device to operate correctly in its electromagnetic environment without causing or suffering harmful interference. Testing covers both emissions and immunity, including proximity to wireless transmitters.

Desensitization that occurs when staff are exposed to excessive numbers of alarms, many of them non-actionable, causing delayed or missed responses. It is a recognized patient safety hazard addressed through alarm management policies.

Configurable thresholds that determine when a monitor sounds an alert for a parameter such as heart rate or oxygen saturation. Defaults are often too wide or too narrow for a given patient population and should be customized.

A noninvasive device that estimates arterial oxygen saturation by comparing light absorption at red and infrared wavelengths across perfused tissue. Readings are unreliable with poor perfusion, motion, or certain dyshemoglobins.

The percentage of hemoglobin binding sites saturated with oxygen as estimated by pulse oximetry. It is a core monitored vital sign but reflects oxygenation rather than ventilation.

Continuous measurement of carbon dioxide in exhaled breath, displayed as a waveform and a numerical end-tidal value. It provides rapid confirmation of airway placement and reflects ventilation and cardiac output.

A system that delivers a controlled mixture of oxygen, carrier gases, and volatile anesthetic while supporting ventilation. Its safety features include oxygen failure alarms, pressure relief valves, and vaporizer interlocks.

A device that moves breathable gas into the lungs and allows exhalation according to set modes, volumes, pressures, and rates. Performance verification covers delivered tidal volume, pressure limits, and alarm function.

A device that delivers fluids or medications intravenously at a controlled rate using peristaltic or syringe mechanisms. Testing focuses on flow rate accuracy, occlusion alarm response, and free-flow protection.

A configured drug formulary within a smart pump that provides concentration limits and dose error reduction alerts. Library updates must be coordinated between pharmacy, nursing, and clinical engineering.

Dividing a network into isolated zones so that traffic and threats cannot move freely between them. Placing medical devices on separate segments from business systems limits the blast radius of a compromise.

The practice of protecting connected medical devices and their data from unauthorized access, tampering, and disruption. It includes inventory, patching, access control, and monitoring across the device lifecycle.

Equipment still in clinical use that runs unsupported operating systems or cannot accept security patches. Such devices require compensating controls like isolation and strict access restriction rather than vendor fixes.

A network security control that permits or blocks traffic according to defined rules between zones. Clinical engineering and IT jointly define rules so that required device communications continue while exposure is minimized.

The piped supply of oxygen, medical air, vacuum, and other gases delivered to bedside outlets throughout a facility. It requires zone valves, alarms, and cross-connection prevention to avoid misadministration.

A monitoring device used in critical care areas that continuously measures leakage current from an ungrounded isolation circuit to ground. It alarms before the hazard current reaches a dangerous level.

An outlet connected to the facility's backup generator system, marked distinctly so staff can identify it during an outage. Life safety and critical care loads must be connected to these circuits.

The scheduled time between service activities for a device, based on manufacturer guidance, risk classification, and usage. Intervals may be extended only with documented justification and appropriate oversight.

A scheduling approach that allocates testing resources according to the likelihood and severity of device failure and its clinical impact. High-risk devices receive more frequent and thorough evaluation.

Repair work performed after a device fault or failure is identified, restoring it to safe operating condition. It is tracked separately from scheduled maintenance to reveal reliability trends.

Verification performed when new equipment arrives or is installed, confirming it meets specifications and is safe before clinical use. It establishes baseline performance data for later comparisons.

The separation of patient-connected circuits from earth and from power circuits using transformers, optical coupling, or insulation. It is the primary design strategy for limiting leakage current through the patient.

The relationship stating that current equals voltage divided by resistance. Technicians use it to predict fault current magnitude and to reason about leakage paths in device circuits.

The total opposition a circuit presents to alternating current, combining resistance and reactance. It determines current magnitude in AC circuits and matters for defibrillation, pacing, and ECG signal quality.

A recording of the heart's electrical activity obtained from surface electrodes placed on the body. It is used to detect arrhythmias, ischemia, and conduction abnormalities and is a common monitored signal.

The volume of blood the heart pumps per minute, equal to heart rate multiplied by stroke volume. It is a key hemodynamic parameter that guides fluid, drug, and device therapy decisions.

The process by which a participant voluntarily agrees to take part in a study after receiving understandable information about risks, benefits, and alternatives. Clinical engineers involved in device trials must respect it.

A situation in which personal, financial, or professional interests could improperly influence technical or clinical judgment. Disclosure and recusal are standard safeguards in device selection and evaluation.

The boundaries of tasks and responsibilities a professional is authorized and competent to perform. Clinical engineers must recognize when a problem requires a licensed clinician or a specialist vendor.